Registration summary
ConferenceICCO
ModeStandard / Physical
ParticipationListener
Registration fee$155.00
Bank charges (5.8%)$8.99
Total payable$163.99
Includes all bank processing charges — the amount above is exactly what will be charged.
Benefits of Registering as Listener
Access to Conference Sessions
Networking Opportunities
Certificate of Participation
Invitation Letter Support
Conference Kit / Materials
Access to Keynote Sessions
• Conference Session Tracks •
SDG-Aligned Research Themes
ICCO conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.
01 Advancements in Anticancer Drug Discovery +
This track focuses on the latest innovations in the development of anticancer drugs, highlighting novel compounds and therapeutic strategies. Researchers are invited to present findings that explore mechanisms of action, efficacy, and safety profiles of new agents.
02 Cancer Biomarkers: Discovery and Application +
This session will delve into the identification and validation of cancer biomarkers that aid in diagnosis, prognosis, and treatment response. Contributions that discuss the clinical implications of biomarker research in various cancer types are particularly encouraged.
03 Innovative Technologies in Cancer Research +
This track showcases cutting-edge technologies and methodologies that are transforming cancer research, including genomics, proteomics, and imaging techniques. Presentations should emphasize how these innovations enhance our understanding of cancer biology and treatment.
04 Clinical Laboratory Advances in Oncology +
This session will explore advancements in clinical laboratory practices that improve cancer diagnosis and monitoring. Topics may include novel diagnostic assays, liquid biopsies, and the integration of laboratory findings into clinical decision-making.
05 Cancer Epidemiology and Prevention Strategies +
This track addresses the epidemiological aspects of cancer, focusing on risk factors, prevention strategies, and public health initiatives. Researchers are encouraged to present studies that highlight effective interventions and population-based approaches to reduce cancer incidence.
06 Chemotherapy and Radiotherapy: Current Trends +
This session will cover the latest developments in chemotherapy and radiotherapy, including combination therapies and personalized treatment approaches. Contributions that discuss the challenges and successes in managing treatment-related toxicities are welcome.
07 End-of-Life Care in Oncology +
This track focuses on the critical aspects of end-of-life care for cancer patients, emphasizing palliative care, symptom management, and psychosocial support. Presentations should address best practices and innovative models of care that enhance the quality of life for patients and families.
08 Gynecologic Oncology: Challenges and Innovations +
This session will explore the unique challenges faced in gynecologic oncology, including early detection, treatment options, and survivorship issues. Researchers are invited to share innovative approaches and research findings that aim to improve outcomes in this field.
09 Genitourinary Cancer: Advances in Diagnosis and Treatment +
This track will focus on the latest advancements in the diagnosis and treatment of genitourinary cancers, including prostate, bladder, and kidney cancers. Contributions that highlight novel therapeutic strategies and clinical trial results are encouraged.
10 The Role of Cancer Nursing and Integrative Medicine +
This session will examine the critical role of nursing in oncology care, including integrative approaches that enhance patient outcomes. Presentations should focus on evidence-based practices and the incorporation of complementary therapies in cancer care.
11 Public Health Policies in Cancer Care +
This track addresses the intersection of cancer care and public health policy, focusing on advocacy, access to care, and health disparities. Researchers are invited to present studies that evaluate the impact of policy changes on cancer prevention and treatment outcomes.
